Edition:
India

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

2.42USD
23 Jan 2018
Change (% chg)

$0.24 (+11.01%)
Prev Close
$2.18
Open
$2.20
Day's High
$2.70
Day's Low
$2.18
Volume
169,996
Avg. Vol
57,426
52-wk High
$106.00
52-wk Low
$2.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.05 -2.083
Jun '17 0.07 -4.127
Mar '17 0.11 -11.657
FY 2016 Dec '16 0.16 -4.582
Sep '16 0.15 -11.830
Jun '16 0.49 -9.672
Mar '16 0.15 -11.342
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.05 0.05 0.05 --
Quarter Ending Jun-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 0.20 0.20 0.20 52.01
Earnings (per share)
Quarter Ending Mar-18 1 -1.80 -1.80 -1.80 --
Quarter Ending Jun-18 1 -1.80 -1.80 -1.80 --
Year Ending Dec-18 1 -7.00 -7.00 -7.00 -23.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.11 32.91
P/E High - Last 5 Yrs. -- 40.94 46.01
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta 1.34 0.90 0.89
Price to Sales (TTM) 20.16 3.98 5.45
Price to Book (MRQ) -- 4.84 5.40
Price to Tangible Book (MRQ) -- 5.58 6.91
Price to Cash Flow (TTM) -- 23.03 23.44
% Owned Institutions 9.44 1.23 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.79 43.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.74 3.67 9.10
Sales (TTM) vs TTM 1 Yr. Ago -44.04 4.71 5.46
Sales - 5 Yr. Growth Rate -34.16 10.04 10.29
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.33 16.65 19.71
EPS (TTM) vs TTM 1 Yr. Ago 43.78 -- --
EPS - 5 Yr. Growth Rate -- 9.84 10.75
Capital Spending - 5 Yr. Growth Rate 128.88 15.23 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.51 2.89 2.98
LT Debt to Equity (MRQ) -- 9.84 12.13
Total Debt to Equity (MRQ) -- 13.84 16.42
Interest Coverage (TTM) -31.06 36.31 33.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.08 54.71
Gross Margin - 5 Yr. Avg. -- 52.36 52.40
EBITD Margin (TTM) -9,409.45 -- --
EBITD - 5 Yr. Avg -1,435.49 18.50 15.28
Operating Margin (TTM) -16,425.43 14.38 7.56
Operating Margin - 5 Yr. Avg. -1,462.72 14.43 10.75
Pre-Tax Margin (TTM) -12,407.62 14.80 8.34
Pre-Tax Margin - 5 Yr. Avg. -1,446.56 14.74 11.15
Net Profit Margin (TTM) -12,407.62 11.07 4.66
Net Profit Margin - 5 Yr. Avg. -1,446.56 11.08 7.45
Effective Tax Rate (TTM) -- 23.18 23.07
Effective Tax Rate - 5 Yr. Avg. -- 23.43 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,978 950,994,078 858,000,222
Net Income/Employee (TTM) -493,610 111,887,536 100,930,107
Receivable Turnover (TTM) 1.93 5.62 5.77
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.01 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -130.36 11.44 11.00
Return on Assets - 5 Yr. Avg. -100.93 12.97 12.38
Return on Investment (TTM) -200.62 14.89 14.44
Return on Investment - 5 Yr. Avg. -133.29 16.97 16.19
Return on Equity (TTM) -- 16.37 16.13
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 82.41 -40.20 -34.16
EPS (TTM) % 54.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Argos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.70%
# of Holders: 35
Total Shares Held: 294,420
3 Mo. Net Change: -1,224
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.